|
Sign In to gain access to subscriptions and/or personal tools.
|
Association Between Retinol-Binding Protein 4 Concentrations and Gestational Diabetes Mellitus and Risk of Developing Metabolic Syndrome After Pregnancy
Zhila Maghbooli, MSc,
Arash Hossein-nezhad, MD, PhD,
Khadijeh Mirzaei, MSc,
Farzaneh Karimi, BS,
Afsaneh Besharati, MD,
Kobra Omidfar, PhD*,
and
Bagher Larijani, MD
* To whom correspondence should be addressed. E-mail: emrc{at}sina.tums.ac.ir.
 |
Abstract |
|---|
The aim of this study was to examine the association between plasma retinol-binding protein 4 (RBP4) and gestational diabetes mellitus (GDM) and the risk of developing metabolic syndrome after pregnancy. In a case-control study, 192 pregnant women (92 with GDM) were recruited. Gestational diabetes mellitus was diagnosed based on OSullivan and Mahan criteria. In all pregnancies, plasma RBP4 concentrations were measured. Retinol-binding protein 4 concentrations in GDM patients were significantly higher than the normal women. Retinol-binding protein 4 level equal to or more than 42 μg/mL could help predict the risk of developing GDM (sensitivity = 75.8%, specificity = 65.3%, P = .001). Concerning metabolic syndrome after pregnancy, in all participants, the prevalence of metabolic syndrome base on World Health Organization (WHO) criteria was 24%. After pregnancy, 32.6% of women with GDM had metabolic syndrome compared with 10.5% of those with healthy pregnancy (P = .001). Age more than 25 years, body mass index (BMI) more than 27 kg/cm2, and RBP4 concentrations were independent risk factors for GDM. Measurement of RBP4 together with the assessment of other risk factors could help identify women at risk of developing GDM.
First published on November 6, 2009 Reproductive Sciences 2009, doi:10.1177/1933719109351097

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|